long description This CE activity was originally presented as a live Group Lecture Series (GLS) beginning October 2013 and has been updated with current JNC 8 guidelines as of June 2014.

After completion of this activity participants will be better able to:

Summarize updates to JNC 8 hypertension treatment guidelines and their relevance to helping patients achieve better blood pressure control.

Develop safe and effective tailored therapeutic regimens for hypertension (taking into account patient comorbidities, side effect profiles of agents, and appropriate combinations of agents).

Use adherence-promoting strategies to empower patients and caregivers and improve outcomes.

Faculty:

Leslie L Davis, PhD, RN, ANP-BC, FAANP, FAHA

Mary Ellen E Roberts, DNP, RN APNC, FAANP, FAAN

This program was planned in accordance with AANP CE Standards and Policies and AANP Commercial Support Standards. The faculty have no relevant affiliations to disclose.

This activity is supported through an independent educational grant from Takeda Pharmaceuticals, U.S.A., Inc.

**The content for this activity is hosted on the organizing sponsor’s website. You will be directed to return to the AANP CE Center to complete the post-test and evaluation.

To complete this activity: Review all the program content on the host website. In the AANP CE Center successfully answer at least 70% of test items on the online post-test and complete the program online evaluation. You will then be able to view/print your certificate of completion. For questions or more information concerning this online CE opportunity please contact Stormy Causey, CE Coordinator atscausey@aanp.org.